| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Vitrolife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 223.60 |
| 52 Week High | SEK 234.20 |
| 52 Week Low | SEK 123.90 |
| Beta | 1.73 |
| 11 Month Change | 30.91% |
| 3 Month Change | 27.63% |
| 1 Year Change | 43.79% |
| 33 Year Change | -53.90% |
| 5 Year Change | 22.72% |
| Change since IPO | 3,049.30% |
Recent News & Updates
Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Jul 20
Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth
Jul 18Recent updates
Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Jul 20Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth
Jul 18Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Mar 07Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now
Feb 05Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion
Jan 05Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching
Dec 15Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Nov 27Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued
Aug 25Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?
May 26Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Sep 09Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
May 26Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly
Mar 31Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Feb 07There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings
Apr 29Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Mar 16Shareholder Returns
| VITR | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | -2.9% | -5.4% | -4.2% |
| 1Y | 43.8% | 18.1% | 12.5% |
Return vs Industry: VITR exceeded the Swedish Biotechs industry which returned 21% over the past year.
Return vs Market: VITR exceeded the Swedish Market which returned 17% over the past year.
Price Volatility
| VITR volatility | |
|---|---|
| VITR Average Weekly Movement | 9.0% |
| Biotechs Industry Average Movement | 8.7% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 12.2% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: VITR's share price has been volatile over the past 3 months.
Volatility Over Time: VITR's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,115 | Bronwyn Brophy O´Connor | www.vitrolife.com |
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems.
Vitrolife AB (publ) Fundamentals Summary
| VITR fundamental statistics | |
|---|---|
| Market cap | SEK 30.27b |
| Earnings (TTM) | -SEK 3.80b |
| Revenue (TTM) | SEK 3.54b |
8.6x
P/S Ratio-8.0x
P/E RatioIs VITR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VITR income statement (TTM) | |
|---|---|
| Revenue | SEK 3.54b |
| Cost of Revenue | SEK 1.50b |
| Gross Profit | SEK 2.03b |
| Other Expenses | SEK 5.83b |
| Earnings | -SEK 3.80b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 24, 2024
| Earnings per share (EPS) | -28.06 |
| Gross Margin | 57.48% |
| Net Profit Margin | -107.47% |
| Debt/Equity Ratio | 15.2% |
How did VITR perform over the long term?
See historical performance and comparison